Evidence map›Paper›PMID 33114589›Full record

ArticleMolecules (Basel, Switzerland)2020

Modulation of Lipid Metabolism by Trans-Anethole in Hepatocytes.

Ahran Song, Yoonjin Park, Boyong Kim, Seung Gwan Lee

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Therapeutic and Pharmaceutical Potential ofAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ahran SongDepartment of Integrated Biomedical and Life Science, College of Health Science, Korea University, Seoul 02841, Korea.ORCID 0000-0001-7528-1749
Yoonjin ParkDepartment of Clinical Laboratory Sciences, College of Health Science, Korea University, Seoul 02841, Korea.ORCID 0000-0002-2394-7542
Boyong KimDepartment of Clinical Laboratory Sciences, College of Health Science, Korea University, Seoul 02841, Korea.ORCID 0000-0003-4029-3824
Seung Gwan LeeDepartment of Integrated Biomedical and Life Science, College of Health Science, Korea University, Seoul 02841, Korea.
Korea University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease is caused by excessive lipid accumulation in hepatocytes. Although trans-anethole (TAO) affects hypoglycemia and has anti-immune activity and anti-obesity effects, its role in non-alcoholic fatty liver disease remains unknown. This study aimed to evaluate the effects of TAO on cellular senescence, lipid metabolism, and reinforcement of microenvironments in HepG2 cells. To analyze the lipid metabolic activity of TAO, PCR analysis, flow-cytometry, and Oil Red O staining were performed, and mitochondrial membrane potential (MMP) and cellular senescence kits were used for assessing the suppression of cellular senescence. At 2000 μg/mL TAO, the cellular viability was approximately 99%, and cell senescence decreased dose-dependently. In the results for MMP, activity increased with concentration. The levels of lipolytic genes,

Indexed as

Allylbenzene DerivativesAnisolesCellular MicroenvironmentCellular SenescenceHepatocytesHep G2 CellsHumansLipid MetabolismMembrane Potential, MitochondrialSignal TransductionAllylbenzene DerivativesanetholeAnisoles5′ AMP-activated protein kinasecellular senescencelipid oxidationnon-alcoholic fatty liver diseasetrans-anethole

Identifiers

PMID33114589
PMCPMC7662808
OpenAlexW3096376165

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.